Henshaw Capital’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
|
|||||
|
2025
Q3 | $827K | Sell |
|
|||||
|
2025
Q2 | $727K | Hold |
|
|||||
|
2025
Q1 | $672K | Hold |
|
|||||
|
2024
Q4 | $685K | Hold |
|
|||||
|
2024
Q3 | $640K | Hold |
|
|||||
|
2024
Q2 | $539K | Buy |
|
|||||
|
2024
Q1 | $460K | Hold |
|
|||||
|
2023
Q4 | $450K | Hold |
|
|||||
|
2023
Q3 | $377K | Buy |
|
|||||
|
2023
Q2 | $256K | Buy |
|
|||||
|
2023
Q1 | $237K | Hold |
|
|||||
|
2022
Q4 | $215K | Sell |
|
|||||
|
2022
Q3 | $278K | Hold |
|
|||||
|
2022
Q2 | $288K | Hold |
|
|||||
|
2022
Q1 | $363K | Buy |
|
|||||
|
2021
Q4 | $418K | Hold |
|
|||||
|
2021
Q3 | $377K | Hold |
|
|||||
|
2021
Q2 | $355K | Hold |
|
|||||
|
2021
Q1 | $412K | Sell |
|
|||||
|
2020
Q4 | $321K | Hold |
|
|||||
|
2020
Q3 | $307K | Hold |
|
|||||
|
2020
Q2 | $361K | Buy |
|
|||||
|
2020
Q1 | $211K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $216K | Buy |
|